Yubo International Biotech Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Yubo International Biotech Limited's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 92% to $104,283. The net income raised on -$1,204,765 and profit margin reached -1155%. Total operating expenses were $1,257,875.

Profit Margin

Yubo International Biotech Limited (OTC:YBGJ): Profit margin
2013 65K -103K -158.46%
2014 60K -106K -176.67%
2015 0 -116K
2016 0 -130K
2017 0 -224K
2018 0 -144K
2019 0 -148K
2020 1.35M -711.80K -52.58%
2021 1.24M -1.54M -123.92%
2022 104.28K -1.20M -1155.28%

YBGJ Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
104.28K1.24M1.35M0000060K65K
Cost of revenue
51.63K423.72K114.27K0000000
Gross profit
52.65K820.64K1.23M0000060K65K
Operating exp.
Research and development
0000000000
Selling and marketing
9.58K182.36K660.96K0000000
Total operating expenses
1.25M2.36M1.95M-48K-58K149K63K-58K-115K-125K
Operating income
-1.20M-1.54M-711.79K-48K-58K-149K-63K-58K-55K-60K
Other income (expenses), net
229427-3-100K-86K-75K-67K-58K-51K-43K
Income before tax
-1.20M-1.54M-711.80K-148K-144K-224K-130K-116K-106K-103K
Income tax expense
-229-42630000000
Net income
-1.20M-1.54M-711.80K-148K-144K-224K-130K-116K-106K-103K
Earnings per share
Basic EPS
-0.01-0.01-0.00-0.13-0.12-0.19-0.11-0.09-0.08-0.08
Diluted EPS
-0.01-0.01-0.00-0.13-0.12-0.19-0.11-0.09-0.08-0.08
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source